CD274 and neoplasm: In cancer patients, the Cancer-Immunity Cycle does not perform optimally, one of the reasons (or most importantly) may be that some immune rheostat factors (such as PD-L1/PD-1) in the tumor microenvironment might be suppressing those Teff cells that are produced.